{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:45:45Z","timestamp":1791355545268,"version":"4.3.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13046-016-0412-1","type":"journal-article","created":{"date-parts":[[2016,9,2]],"date-time":"2016-09-02T06:03:19Z","timestamp":1472796199000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":128,"title":["Deletion of interleukin-6 in monocytes\/macrophages suppresses the initiation of hepatocellular carcinoma in mice"],"prefix":"10.1186","volume":"35","author":[{"given":"Lingxiang","family":"Kong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,2]]},"reference":[{"key":"412_CR1","doi-asserted-by":"crossref","first-page":"513","DOI":"10.4254\/wjh.v8.i11.513","volume":"8","author":"M Garancini","year":"2016","unstructured":"Garancini M, Pinotti E, Nespoli S, et al. Hepatic resection beyond barcelona clinic liver cancer indication: when and how. World J Hepatol. 2016;8:513\u20139.","journal-title":"World J Hepatol"},{"key":"412_CR2","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","volume":"140","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140:883\u201399.","journal-title":"Cell"},{"key":"412_CR3","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/nrm2455","volume":"9","author":"M Schafer","year":"2008","unstructured":"Schafer M, Werner S. Cancer as an overhealing wound: an old hypothesis revisited. Nat Rev Mol Cell Biol. 2008;9:628\u201338.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"412_CR4","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1054\/bjoc.2001.1943","volume":"85","author":"KJ O'Byrne","year":"2001","unstructured":"O'Byrne KJ, Dalgleish AG. Chronic immune activation and inflammation as the cause of malignancy. Br J Cancer. 2001;85:473\u201383.","journal-title":"Br J Cancer"},{"key":"412_CR5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(10)62110-1","volume":"377","author":"PM Rothwell","year":"2011","unstructured":"Rothwell PM, Fowkes FG, Belch JF, et al. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet. 2011;377:31\u201341.","journal-title":"Lancet"},{"key":"412_CR6","doi-asserted-by":"crossref","first-page":"S1-","DOI":"10.1046\/j.1440-1746.1999.01903.x","volume":"14 Suppl","author":"JC Imperial","year":"1999","unstructured":"Imperial JC. Natural history of chronic hepatitis B and C. J Gastroenterol Hepatol. 1999;14 Suppl:S1-\u20135.","journal-title":"J Gastroenterol Hepatol"},{"key":"412_CR7","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1146\/annurev-pathol-012414-040323","volume":"10","author":"MV Lin","year":"2015","unstructured":"Lin MV, King LY, Chung RT. Hepatitis C virus-associated cancer. Annu Rev Pathol. 2015;10:345\u201370.","journal-title":"Annu Rev Pathol"},{"key":"412_CR8","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/S0140-6736(14)60220-8","volume":"384","author":"C Trepo","year":"2014","unstructured":"Trepo C, Chan HL, Lok A. Hepatitis B virus infection. Lancet. 2014;384:2053\u201363.","journal-title":"Lancet"},{"key":"412_CR9","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1158\/0008-5472.CAN-05-4005","volume":"66","author":"CE Lewis","year":"2006","unstructured":"Lewis CE, Pollard JW. Distinct role of macrophages in different tumor microenvironments. Cancer Res. 2006;66:605\u201312.","journal-title":"Cancer Res"},{"key":"412_CR10","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.imbio.2009.06.014","volume":"214","author":"C Porta","year":"2009","unstructured":"Porta C, Larghi P, Rimoldi M, et al. Cellular and molecular pathways linking inflammation and cancer. Immunobiology. 2009;214:761\u201377.","journal-title":"Immunobiology"},{"key":"412_CR11","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.cryobiol.2006.12.005","volume":"54","author":"P Walbrun","year":"2007","unstructured":"Walbrun P, Hellerbrand C, Weiss TS, et al. Characterization of rat and human Kupffer cells after cryopreservation. Cryobiology. 2007;54:164\u201372.","journal-title":"Cryobiology"},{"key":"412_CR12","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","volume":"115","author":"R Bataller","year":"2005","unstructured":"Bataller R, Brenner DA. Liver fibrosis. J Clin Invest. 2005;115:209\u201318.","journal-title":"J Clin Invest"},{"key":"412_CR13","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.coi.2010.01.009","volume":"22","author":"A Mantovani","year":"2010","unstructured":"Mantovani A, Sica A. Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Curr Opin Immunol. 2010;22:231\u20137.","journal-title":"Curr Opin Immunol"},{"key":"412_CR14","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1471-4906(02)02302-5","volume":"23","author":"A Mantovani","year":"2002","unstructured":"Mantovani A, Sozzani S, Locati M, et al. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends In Immunology. 2002;23:549\u201355.","journal-title":"Trends In Immunology"},{"key":"412_CR15","doi-asserted-by":"crossref","first-page":"187204","DOI":"10.1155\/2013\/187204","volume":"2013","author":"D Capece","year":"2013","unstructured":"Capece D, Fischietti M, Verzella D, et al. The inflammatory microenvironment in hepatocellular carcinoma: a pivotal role for tumor-associated macrophages. Biomed Res Int. 2013;2013:187204.","journal-title":"Biomed Res Int"},{"key":"412_CR16","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1016\/j.ejca.2005.08.016","volume":"41","author":"DR Hodge","year":"2005","unstructured":"Hodge DR, Hurt EM, Farrar WL. The role of IL-6 and STAT3 in inflammation and cancer. Eur J Cancer. 2005;41:2502\u201312.","journal-title":"Eur J Cancer"},{"key":"412_CR17","doi-asserted-by":"crossref","first-page":"10847","DOI":"10.1074\/jbc.M110.217653","volume":"286","author":"RS Tacke","year":"2011","unstructured":"Tacke RS, Tosello-Trampont A, Nguyen V, et al. Extracellular hepatitis C virus core protein activates STAT3 in human monocytes\/macrophages\/dendritic cells via an IL-6 autocrine pathway*. J Biol Chem. 2011;286:10847\u201355.","journal-title":"J Biol Chem"},{"key":"412_CR18","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1111\/j.1478-3231.2011.02742.x","volume":"32","author":"JT Kao","year":"2012","unstructured":"Kao JT, Lai HC, Tsai SM, et al. Rather than interleukin-27, interleukin-6 expresses positive correlation with liver severity in naive hepatitis B infection patients. Liver Int. 2012;32:928\u201336.","journal-title":"Liver Int"},{"key":"412_CR19","doi-asserted-by":"crossref","first-page":"7251","DOI":"10.1073\/pnas.84.20.7251","volume":"84","author":"J Gauldie","year":"1987","unstructured":"Gauldie J, Richards C, Harnish D, et al. Interferon beta 2\/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc Natl Acad Sci U S A. 1987;84:7251\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"412_CR20","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1056\/NEJM199902113400607","volume":"340","author":"C Gabay","year":"1999","unstructured":"Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340:448\u201354.","journal-title":"N Engl J Med"},{"issue":"Pt 2","key":"412_CR21","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/bj3340297","volume":"334","author":"PC Heinrich","year":"1998","unstructured":"Heinrich PC, Behrmann I, Muller-Newen G, et al. Interleukin-6-type cytokine signalling through the gp130\/Jak\/STAT pathway. Biochem J. 1998;334(Pt 2):297\u2013314.","journal-title":"Biochem J"},{"key":"412_CR22","first-page":"58","volume":"1","author":"C Johnson","year":"2012","unstructured":"Johnson C, Han Y, Hughart N, et al. Interleukin-6 and its receptor, key players in hepatobiliary inflammation and cancer. Transl Gastrointest Cancer. 2012;1:58\u201370.","journal-title":"Transl Gastrointest Cancer"},{"key":"412_CR23","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1053\/jhep.2003.50378","volume":"38","author":"A Blindenbacher","year":"2003","unstructured":"Blindenbacher A, Wang X, Langer I, et al. Interleukin 6 is important for survival after partial hepatectomy in mice. Hepatology. 2003;38:674\u201382.","journal-title":"Hepatology"},{"key":"412_CR24","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.cyto.2008.03.012","volume":"42","author":"GA Tiberio","year":"2008","unstructured":"Tiberio GA, Tiberio L, Benetti A, et al. IL-6 Promotes compensatory liver regeneration in cirrhotic rat after partial hepatectomy. Cytokine. 2008;42:372\u20138.","journal-title":"Cytokine"},{"key":"412_CR25","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1053\/jhep.2003.50268","volume":"38","author":"KL Streetz","year":"2003","unstructured":"Streetz KL, Tacke F, Leifeld L, et al. Interleukin 6\/gp130-dependent pathways are protective during chronic liver diseases. Hepatology. 2003;38:218\u201329.","journal-title":"Hepatology"},{"key":"412_CR26","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1111\/j.1572-0241.2007.01774.x","volume":"103","author":"A Wieckowska","year":"2008","unstructured":"Wieckowska A, Papouchado BG, Li Z, et al. Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis. Am J Gastroenterol. 2008;103:1372\u20139.","journal-title":"Am J Gastroenterol"},{"key":"412_CR27","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1053\/j.gastro.2004.09.013","volume":"127","author":"HB El-Serag","year":"2004","unstructured":"El-Serag HB. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology. 2004;127:S27\u201334.","journal-title":"Gastroenterology"},{"key":"412_CR28","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ejso.2006.10.036","volume":"33","author":"CY Hsia","year":"2007","unstructured":"Hsia CY, Huo TI, Chiang SY, et al. Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma. Eur J Surg Oncol. 2007;33:208\u201312.","journal-title":"Eur J Surg Oncol"},{"key":"412_CR29","first-page":"1237","volume":"145","author":"TH Mauad","year":"1994","unstructured":"Mauad TH, van Nieuwkerk CM, Dingemans KP, et al. Mice with homozygous disruption of the mdr2 P-glycoprotein gene. A novel animal model for studies of nonsuppurative inflammatory cholangitis and hepatocarcinogenesis. Am J Pathol. 1994;145:1237\u201345.","journal-title":"Am J Pathol"},{"key":"412_CR30","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1631\/jzus.B1000422","volume":"12","author":"JZ Di","year":"2011","unstructured":"Di JZ, Han XD, Gu WY, et al. Association of hypomethylation of LINE-1 repetitive element in blood leukocyte DNA with an increased risk of hepatocellular carcinoma. J Zhejiang Univ Sci B. 2011;12:805\u201311.","journal-title":"J Zhejiang Univ Sci B"},{"key":"412_CR31","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1674-8301(10)60042-5","volume":"24","author":"L Yan","year":"2010","unstructured":"Yan L, Zhu T, Sun T, et al. Activation of calcium-sensing receptors is associated with apoptosis in a model of simulated cardiomyocytes ischemia\/reperfusion. J Biomed Res. 2010;24:301\u20137.","journal-title":"J Biomed Res"},{"key":"412_CR32","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/01.shk.0000144423.40270.96","volume":"23","author":"M Kinoshita","year":"2005","unstructured":"Kinoshita M, Uchida T, Nakashima H, et al. Opposite effects of enhanced tumor necrosis factor-alpha production from Kupffer cells by gadolinium chloride on liver injury\/mortality in endotoxemia of normal and partially hepatectomized mice. Shock. 2005;23:65\u201372.","journal-title":"Shock"},{"key":"412_CR33","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1006\/taap.2002.9385","volume":"180","author":"EB Harstad","year":"2002","unstructured":"Harstad EB, Klaassen CD. Gadolinium chloride pretreatment prevents cadmium chloride-induced liver damage in both wild-type and MT-null mice. Toxicol Appl Pharmacol. 2002;180:178\u201385.","journal-title":"Toxicol Appl Pharmacol"},{"key":"412_CR34","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0300-483X(97)00065-6","volume":"121","author":"DA Badger","year":"1997","unstructured":"Badger DA, Kuester RK, Sauer JM, et al. Gadolinium chloride reduces cytochrome P450: relevance to chemical-induced hepatotoxicity. Toxicology. 1997;121:143\u201353.","journal-title":"Toxicology"},{"key":"412_CR35","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.freeradbiomed.2004.03.021","volume":"37","author":"DX Xu","year":"2004","unstructured":"Xu DX, Wei W, Sun MF, et al. Kupffer cells and reactive oxygen species partially mediate lipopolysaccharide-induced downregulation of nuclear receptor pregnane x receptor and its target gene CYP3a in mouse liver. Free Radic Biol Med. 2004;37:10\u201322.","journal-title":"Free Radic Biol Med"},{"key":"412_CR36","doi-asserted-by":"crossref","first-page":"11029","DOI":"10.1073\/pnas.0502677102","volume":"102","author":"G Bradshaw","year":"2005","unstructured":"Bradshaw G, Gutierrez A, Miyake JH, et al. Facilitated replacement of Kupffer cells expressing a paraoxonase-1 transgene is essential for ameliorating atherosclerosis in mice. Proc Natl Acad Sci U S A. 2005;102:11029\u201334.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"412_CR37","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/j.transproceed.2004.09.006","volume":"36","author":"KY Chung","year":"2004","unstructured":"Chung KY, Jeong GY, Choi KB, et al. Prevention of primary nonfunction after canine liver allotransplantation: the effect of gadolinium chloride. Transplant Proc. 2004;36:1928\u201330.","journal-title":"Transplant Proc"},{"key":"412_CR38","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/hep.510310123","volume":"31","author":"K Kovalovich","year":"2000","unstructured":"Kovalovich K, DeAngelis RA, Li W, et al. Increased toxin-induced liver injury and fibrosis in interleukin-6-deficient mice. Hepatology. 2000;31:149\u201359.","journal-title":"Hepatology"},{"key":"412_CR39","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1002\/ijc.24281","volume":"124","author":"VW Wong","year":"2009","unstructured":"Wong VW, Yu J, Cheng AS, et al. High serum interleukin-6 level predicts future hepatocellular carcinoma development in patients with chronic hepatitis B. Int J Cancer. 2009;124:2766\u201370.","journal-title":"Int J Cancer"},{"key":"412_CR40","doi-asserted-by":"crossref","first-page":"78380","DOI":"10.1155\/MI\/2006\/78380","volume":"2006","author":"H Ataseven","year":"2006","unstructured":"Ataseven H, Bahcecioglu IH, Kuzu N, et al. The levels of ghrelin, leptin, TNF-alpha, and IL-6 in liver cirrhosis and hepatocellular carcinoma due to HBV and HDV infection. Mediat Inflamm. 2006;2006:78380.","journal-title":"Mediat Inflamm"},{"key":"412_CR41","first-page":"2207","volume":"107","author":"H Barash","year":"2010","unstructured":"Barash H, R Gross E, Edrei Y, et al. Accelerated carcinogenesis following liver regeneration is associated with chronic inflammation-induced double-strand DNA breaks. Proc Natl Acad Sci U S A. 2010;107:2207\u201312.","journal-title":"Accelerated carcinogenesis following liver regeneration is associated with chronic inflammation-induced double-strand DNA breaks. Proc Natl Acad Sci U S A."},{"key":"412_CR42","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1002\/cncr.28730","volume":"120","author":"ZV Fong","year":"2014","unstructured":"Fong ZV, Tanabe KK. The clinical management of hepatocellular carcinoma in the United States, Europe, and Asia: a comprehensive and evidence-based comparison and review. Cancer. 2014;120:2824\u201338.","journal-title":"Cancer"},{"key":"412_CR43","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nrc2734","volume":"9","author":"H Yu","year":"2009","unstructured":"Yu H, Pardoll D, Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer. 2009;9:798\u2013809.","journal-title":"Nat Rev Cancer"},{"key":"412_CR44","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cell.2009.12.052","volume":"140","author":"EJ Park","year":"2010","unstructured":"Park EJ, Lee JH, Yu GY, et al. Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell. 2010;140:197\u2013208.","journal-title":"Cell"},{"key":"412_CR45","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ccr.2007.12.020","volume":"13","author":"S Grivennikov","year":"2008","unstructured":"Grivennikov S, Karin M. Autocrine IL-6 signaling: a key event in tumorigenesis? Cancer Cell. 2008;13:7\u20139.","journal-title":"Cancer Cell"},{"key":"412_CR46","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ccr.2009.01.009","volume":"15","author":"J Bromberg","year":"2009","unstructured":"Bromberg J, Wang TC. Inflammation and cancer: IL-6 and STAT3 complete the link. Cancer Cell. 2009;15:79\u201380.","journal-title":"Cancer Cell"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-016-0412-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T17:51:15Z","timestamp":1498326675000},"score":1,"resource":{"primary":{"URL":"http:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-016-0412-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,2]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["412"],"URL":"https:\/\/doi.org\/10.1186\/s13046-016-0412-1","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,2]]},"article-number":"131"}}